Skip to main content
Timothy Olson, MD, Pediatric Hematology & Oncology, Philadelphia, PA

TimothyOlsonMDPh.D.

Pediatric Hematology & Oncology Philadelphia, PA

Assistant Professor of Pediatrics Children's Hospital of Philadelphia University of Pennsylvania

Dr. Olson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Olson's full profile

Already have an account?

  • Office

    3401 Civic Center Blvd
    # Children
    Philadelphia, PA 19104
    Phone+1 215-590-3535
    Fax+1 215-590-3992

Education & Training

  • Children's Hospital of Philadelphia
    Children's Hospital of PhiladelphiaFellowship, Pediatric Hematology/Oncology, 2008 - 2012
  • Children's Hospital of Philadelphia
    Children's Hospital of PhiladelphiaResidency, Pediatrics, 2006 - 2008
  • University of Virginia School of Medicine
    University of Virginia School of MedicineClass of 2006

Certifications & Licensure

  • DE State Medical License
    DE State Medical License Current
  • PA State Medical License
    PA State Medical License 2006 - 2024
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Germline Duplication of ATG2B and GSKIP Genes Is Not Required for the Familial Myeloid Malignancy Syndrome Associated with the Duplication of Chromosome 14q32  
    David B Lieberman, Daria V Babushok, Timothy S Olson, Stella T Chou, Elizabeth O Hexner, Nature

Abstracts/Posters

  • Inducible SBDS Deficiency Impairs Bone Marrow Niche Function to Engraft Donor Hematopoietic Stem Cell after Transplantation
    Timothy S. Olson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

  • Inherited Hematopoietic Malignancies 
    60th American Society of Hematology Annual Meeting - 11/30/2018

Press Mentions

  • Turn Biotechnologies Announces Landmark Study to Assess Effectiveness of ERA™ Therapy in Restoring Bone Marrow USA - English USA - Français USA - Nederlands Japan - Japanese Korea - 한국어 APAC - English USA - Deutsch
    Turn Biotechnologies Announces Landmark Study to Assess Effectiveness of ERA™ Therapy in Restoring Bone Marrow USA - English USA - Français USA - Nederlands Japan - Japanese Korea - 한국어 APAC - English USA - DeutschDecember 3rd, 2024
  • Turn Biotechnologies Announces Landmark Study to Assess Effectiveness of ERA™ Therapy in Restoring Bone Marrow
    Turn Biotechnologies Announces Landmark Study to Assess Effectiveness of ERA™ Therapy in Restoring Bone MarrowDecember 3rd, 2024
  • Turn Bio Commences Bone Marrow Rejuvenation Study
    Turn Bio Commences Bone Marrow Rejuvenation StudyDecember 3rd, 2024

Professional Memberships